Supplementary Table S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients

Supplementary Table S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients

<p>Supplementary Table 2. Complete table results for all patients (n=201) involved in baseline (C1D1) analysis.</p>

Đã lưu trong:

Chi tiết về thư mục
Tác giả chính:	Javier Pascual (15018176) (author)
Tác giả khác:	Miguel Gil-Gil (15052083) (author), Paula Proszek (17141889) (author), Christoph Zielinski (15054460) (author), Alistair Reay (17141892) (author), Manuel Ruiz-Borrego (15048425) (author), Rosalind Cutts (17141895) (author), Eva M. Ciruelos Gil (17141898) (author), Andrew Feber (15124144) (author), Montserrat Muñoz-Mateu (15054469) (author), Claire Swift (17141901) (author), Begoña Bermejo (15037896) (author), Jesus Herranz (15048443) (author), Mireia Margeli Vila (15054472) (author), Antonio Antón (15054475) (author), Zsuzsanna Kahan (17141904) (author), Tibor Csöszi (17141907) (author), Yuan Liu (15054484) (author), Daniel Fernandez-Garcia (17141910) (author), Isaac Garcia-Murillas (15018188) (author), Michael Hubank (15104113) (author), Nicholas C. Turner (17141913) (author), Miguel Martín (15011399) (author)
Được phát hành:	2025
Những chủ đề:	Cancer Cancer Detection and Diagnosis Therapeutic Research and Development Biomarkers Circulating tumor cells/DNA/exosomes Serum biomarkers Breast Cancer Translational Research
Các nhãn:	Thêm thẻ Không có thẻ, Là người đầu tiên thẻ bản ghi này!

Những quyển sách tương tự

Supplementary Figure S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
Bằng: Javier Pascual (15018176)
Được phát hành: (2025)

Supplementary Figure S1 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
Bằng: Javier Pascual (15018176)
Được phát hành: (2025)

Supplementary Figure S3 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
Bằng: Javier Pascual (15018176)
Được phát hành: (2025)

Supplementary Figure S4 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
Bằng: Javier Pascual (15018176)
Được phát hành: (2025)

Supplementary Figure S5 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
Bằng: Javier Pascual (15018176)
Được phát hành: (2025)

Supplementary Table S3 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
Bằng: Javier Pascual (15018176)
Được phát hành: (2025)

Supplemental Table 2 from Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
Bằng: Morten Lapin (15056728)
Được phát hành: (2025)

Supplemental Table 1 from Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
Bằng: Morten Lapin (15056728)
Được phát hành: (2025)

Supplemental Table 3 from Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
Bằng: Morten Lapin (15056728)
Được phát hành: (2025)

Supplementary Data S1 from Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HR+)/HER2-Negative Metastatic Breast Cancer
Bằng: Andrew A. Davis (15030032)
Được phát hành: (2025)

Supplementary Figure S7 from <i>NPY</i> Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer
Bằng: Katleen Janssens (15053356)
Được phát hành: (2025)

Supplementary Table S3 from Circulating Exosomal PD-L1 at Initial Diagnosis Predicts Outcome and Survival of Patients with Osteosarcoma
Bằng: Jun Wang (15051911)
Được phát hành: (2025)

TS1-9 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
Bằng: Lavanya Sivapalan (15314248)
Được phát hành: (2025)

Supplementary Table S2 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Bằng: Sofie H. Tolmeijer (15313251)
Được phát hành: (2025)

Supplementary Table S1 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Bằng: Sofie H. Tolmeijer (15313251)
Được phát hành: (2025)

Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Bằng: Sofie H. Tolmeijer (15313251)
Được phát hành: (2025)

Supplementary Data 2 from Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study
Bằng: Ismael Fernández-Miranda (15051932)
Được phát hành: (2025)

Table S1-S8 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
Bằng: Ruiyun Zhang (17142498)
Được phát hành: (2025)

Supplementary Data 1 from Monitoring Sarcoma Response to Immune Checkpoint Inhibition and Local Cryotherapy with Circulating Tumor DNA Analysis
Bằng: Nam Q. Bui (14958210)
Được phát hành: (2025)

Table 1_Cross-species validation of a 6-miRNA blood signature for Parkinson’s disease: from MPTP mice to human PBMC and serum exosomes.docx
Bằng: Nagyum Jung (22686458)
Được phát hành: (2025)

Figure 2 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
Bằng: Nigel Bundred (15046233)
Được phát hành: (2025)

Table 2 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
Bằng: Nigel Bundred (15046233)
Được phát hành: (2025)

Figure 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
Bằng: Nigel Bundred (15046233)
Được phát hành: (2025)

Figure 3 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
Bằng: Nigel Bundred (15046233)
Được phát hành: (2025)

Table 1 from Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results
Bằng: Nigel Bundred (15046233)
Được phát hành: (2025)

Supplementary Fig. S2 from The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer
Bằng: Sahar Mafi (16721657)
Được phát hành: (2025)

Figure S2 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
Bằng: Jamunarani Veeraraghavan (16461809)
Được phát hành: (2025)

Figure S1 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
Bằng: Jamunarani Veeraraghavan (16461809)
Được phát hành: (2025)

Figure S3 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
Bằng: Jamunarani Veeraraghavan (16461809)
Được phát hành: (2025)

Figure S4 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
Bằng: Jamunarani Veeraraghavan (16461809)
Được phát hành: (2025)

Figure S5 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
Bằng: Jamunarani Veeraraghavan (16461809)
Được phát hành: (2025)

Figure S6 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
Bằng: Jamunarani Veeraraghavan (16461809)
Được phát hành: (2025)

Supplementary Tables 1 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
Bằng: Jamunarani Veeraraghavan (16461809)
Được phát hành: (2025)

Supplementary Video S2A from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
Bằng: Xiaojiang Duan (15439264)
Được phát hành: (2025)

Supplementary Video S2B from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
Bằng: Xiaojiang Duan (15439264)
Được phát hành: (2025)

Supplementary Video S2C from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
Bằng: Xiaojiang Duan (15439264)
Được phát hành: (2025)

Figure 2 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers
Bằng: Milana A. Bergamino (15038015)
Được phát hành: (2025)

Supplementary Fig. S1 from The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer
Bằng: Sahar Mafi (16721657)
Được phát hành: (2025)

Movie S2 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics
Bằng: Jill Gallaher (16799594)
Được phát hành: (2025)

Supplementary Video S1 from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
Bằng: Xiaojiang Duan (15439264)
Được phát hành: (2025)

Cannot write session to /tmp/vufind_sessions/sess_om2arucetnecl4akiifq3c3rvt